Publication | Open Access

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Sars-cov-2 InfectionCovid-19 PandemicImmunologyAntiviral TherapyRespiratory InfectionMedicineCovid-19